Cannara Biotech Inc. (TSXV:LOVE)

Canada flag Canada · Delayed Price · Currency is CAD
1.290
+0.040 (3.20%)
Feb 21, 2025, 3:55 PM EST
43.33%
Market Cap 116.93M
Revenue (ttm) 87.28M
Net Income (ttm) 6.64M
Shares Out 90.64M
EPS (ttm) 0.07
PE Ratio 17.50
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 42,942
Average Volume 46,637
Open 1.250
Previous Close 1.250
Day's Range 1.230 - 1.300
52-Week Range 0.520 - 1.350
Beta 1.21
RSI 70.84
Earnings Date Jan 24, 2025

About Cannara Biotech

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada. [Read more]

Sector Healthcare
Founded 2017
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol LOVE
Full Company Profile

Financial Performance

In 2024, Cannara Biotech's revenue was 81.75 million, an increase of 42.77% compared to the previous year's 57.26 million. Earnings were 6.44 million, a decrease of -7.30%.

Financial Statements

News

There is no news available yet.